Integrated proteogenomic characterization across major histological types of pediatric brain cancer F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ... Cell 183 (7), 1962-1985. e31, 2020 | 213 | 2020 |
Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ... Cancer cell 32 (3), 295-309. e12, 2017 | 175 | 2017 |
Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design JL Rokita, KS Rathi, MF Cardenas, KA Upton, J Jayaseelan, KL Cross, ... Cell reports 29 (6), 1675-1689. e9, 2019 | 155 | 2019 |
Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines JL Harenza, MA Diamond, RN Adams, MM Song, HL Davidson, LS Hart, ... Scientific Data 4 (1), 1-9, 2017 | 146 | 2017 |
Cross-cohort analysis identifies a TEAD4–MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma P Rajbhandari, G Lopez, C Capdevila, B Salvatori, J Yu, ... Cancer discovery 8 (5), 582-599, 2018 | 132 | 2018 |
Telomere maintenance mechanisms define clinical outcome in high-risk neuroblastoma B Koneru, G Lopez, A Farooqi, KL Conkrite, TH Nguyen, SJ Macha, ... Cancer research 80 (12), 2663-2675, 2020 | 72 | 2020 |
ASCL1 is a MYCN-and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry L Wang, TK Tan, AD Durbin, MW Zimmerman, BJ Abraham, SH Tan, ... Nature communications 10 (1), 5622, 2019 | 68 | 2019 |
The pediatric cell atlas: defining the growth phase of human development at single-cell resolution DM Taylor, BJ Aronow, K Tan, K Bernt, N Salomonis, CS Greene, ... Developmental cell 49 (1), 10-29, 2019 | 64 | 2019 |
Epigenomic profiling of neuroblastoma cell lines K Upton, A Modi, K Patel, NM Kendsersky, KL Conkrite, RT Sussman, ... Scientific data 7 (1), 116, 2020 | 63 | 2020 |
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition J Voeller, AK Erbe, J Slowinski, K Rasmussen, PM Carlson, A Hoefges, ... Journal for ImmunoTherapy of Cancer 7, 1-13, 2019 | 63 | 2019 |
YAP1 mediates resistance to MEK1/2 inhibition in neuroblastomas with hyperactivated RAS signaling GE Coggins, A Farrel, KS Rathi, CM Hayes, L Scolaro, JL Rokita, ... Cancer research 79 (24), 6204-6214, 2019 | 55 | 2019 |
Genetic variation within the Chrna7 gene modulates nicotine reward‐like phenotypes in mice JL Harenza, PP Muldoon, M De Biasi, MI Damaj, MF Miles Genes, Brain and Behavior 13 (2), 213-225, 2014 | 47 | 2014 |
Inhibition of monoacylglycerol lipase reduces nicotine withdrawal PP Muldoon, J Chen, JL Harenza, RA Abdullah, LJ Sim‐Selley, ... British journal of pharmacology 172 (3), 869-882, 2015 | 46 | 2015 |
International comparison of enumeration-based quantification of DNA copy-concentration using flow cytometric counting and digital polymerase chain reaction HB Yoo, SR Park, L Dong, J Wang, Z Sui, J Pavšič, M Milavec, ... Analytical chemistry 88 (24), 12169-12176, 2016 | 43 | 2016 |
The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence KJ Jackson, X Chen, MF Miles, JL Harenza, MI Damaj Neuropsychopharmacology 36 (11), 2339-2348, 2011 | 43 | 2011 |
The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies PP Muldoon, KJ Jackson, E Perez, JL Harenza, S Molas, B Rais, H Anwar, ... British Journal of Pharmacology 171 (16), 3845-3857, 2014 | 42 | 2014 |
Germline 16p11. 2 microdeletion predisposes to neuroblastoma LE Egolf, Z Vaksman, G Lopez, JL Rokita, A Modi, PV Basta, ... The American Journal of Human Genetics 105 (3), 658-668, 2019 | 40 | 2019 |
Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003 C Kline, P Jain, L Kilburn, ER Bonner, N Gupta, JR Crawford, A Banerjee, ... Clinical Cancer Research 28 (18), 3965-3978, 2022 | 35 | 2022 |
Pediatric high-grade glioma resources from the Children’s Brain Tumor Tissue Consortium H Ijaz, M Koptyra, KS Gaonkar, JL Rokita, VP Baubet, L Tauhid, Y Zhu, ... Neuro-oncology 22 (1), 163-165, 2020 | 35 | 2020 |
Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality MT Dang, MV Gonzalez, KS Gaonkar, KS Rathi, P Young, S Arif, L Zhai, ... Cell reports 34 (13), 2021 | 34 | 2021 |